San Antonio Breast Cancer Symposium In January, Fox Chase hosted its 13th Annual Highlights from the San Antonio Breast Cancer Symposium in collaboration with OncLive. Led by Lori J. Goldstein, MD, FASCO, the program included faculty from both Fox Chase Cancer Center and the University of Pennsylvania. More than 170 physicians and nurses attended the program in Philadelphia, which provided relevant updates on the management of breast cancer and premalignant breast disease. The event has come to be regarded by local clinicians as a critical resource for learning about recent research findings and advances in breast cancer care. American Society … Continue Reading »
GI Clinical Trials Make Meeting Headlines Fox Chase was well represented at the annual GI ASCO Symposium in January. Many fellows, residents, and faculty members attended, with nine making poster presentations on topics around esophageal, pancreatic, and colorectal cancers. Medical oncologist Wafik El-Deiry, MD, PhD, FACP, also presented oral abstracts on two anti-angiogenic agents for metastatic colorectal cancer (mCRC) going through Phase II and III trials. His discussion made headline news at the Symposium.
Fox Chase Presents on Disparities in Cancer Prevention and Treatment In November 2014, Evelyn González (far left), senior director of the Fox Chase Office of Health Communications and Health Disparities, presented at the seventh AACR conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. During her presentation, González shared information on why it is important to include different racial and ethnic groups when embarking on new and improved methods of cancer screening, prevention, and treatment.
Survivorship Care Guidelines for Non-Small Cell Lung and Colorectal Cancers Medical oncologist Crystal Denlinger, MD, presented new results from her project titled “Adherence to NCCN Survivorship Care Guidelines in Non-Small Cell Lung Cancer (NSCLC) and Colorectal Cancer (CRC)” at the National Comprehensive Cancer Network’s 20th annual conference in March. Denlinger and colleagues found that comprehensive assessment guidelines for NSCLC and CRC survivors were not regularly met, although adherence increased somewhat after providers received an educational intervention focused on survivorship care. The research, presented at the conference’s general poster session, was funded through Denlinger’s NCCN Foundation 2012 Young Investigator Award. Denlinger … Continue Reading »
One of the most exciting new areas in cancer research is a class of monoclonal antibodies that targets immune system checkpoints—specifically, the programmed cell death protein 1 (PD-1) expressed on T-cell membranes. By binding its ligand PD-L1, PD-1 downregulates T cells and prevents autoimmune reactions. Continue Reading »
Since joining Fox Chase in 1991 as chief of head and neck surgery, John A. Ridge has been dedicated to developing treatments and surgical techniques that cure head and neck cancers while allowing patients to maintain a high quality of life. Nationally recognized, Ridge focuses his clinical practice on head and neck and endocrine tumors, including nonsurgical management, organ preservation, new surgical techniques, and early and advanced thyroid tumors. As a co-chair of the National Cancer Institute’s Head and Neck Cancer Steering Committee, he helps coordinate and direct federally funded clinical research in the field, setting the agenda for the … Continue Reading »
The American Academy of Hospice and Palliative Medicine has honored Michael H. Levy, MD, PhD, director of Fox Chase’s pain and palliative care program, with its 2015 Lifetime Achievement Award. The award recognizes Levy’s outstanding contributions and significant publications that have helped shape the field of hospice and palliative medicine. Levy, who is considered a leader of the American hospice and palliative care movement, is also chair of the NCCN Palliative Care Guidelines panel and a member of the Technical Advisory Panel for the first update of The Joint Commission’s palliative care standards.
Surgical oncologist Jeffrey Farma, MD, FACS, was invited last fall to Germany as the 2014 American College of Surgeons (ACS) Traveling Fellow. The fellowship provided Farma with a better understanding of German surgical training and education and the country’s national health care system, specifically multidisciplinary cancer care and clinical trial procedures. Farma visited six medical centers and attended the 131st Congress of the German Society for Surgery (GSS) in Berlin, where he presented in the session, “Changing the Treatment Paradigm for Locally Advanced Rectal Cancer.” During the Congress, he also talked about his experience as an ACS scholar and participated … Continue Reading »